August 2025 in “Clinical and Experimental Dermatology” This study found that although patients with significant scalp hair loss experienced substantial reductions in Severity of Alopecia Tool scores, few maintained this improvement over time, indicating potential suboptimal effectiveness of current treatments.
In this retrospective study of alopecia areata patients across several European countries, researchers observed a notable reduction in SALT scores, but few patients reached or maintained a clinically significant SALT score of ≤20, indicating potentially limited effectiveness of current treatments for extensive hair loss.
January 2026 in “White Rose Research Online (University of Leeds, The University of Sheffield, University of York)” This study found that while patients with alopecia areata in Europe experienced substantial reductions in hair loss severity, only a few achieved and sustained a significant improvement in their condition.
8 citations
,
August 2024 in “Clinical and Experimental Dermatology” This review discusses the limitations of existing clinician-reported outcome measures for alopecia areata and emphasizes the need for a composite scoring system to better assess disease severity.
2 citations
,
March 2019 in “PubMed” This report presents the early development of the Lupus Foundation of America's LFA-REAL™ patient-reported instrument, designed to enhance evaluation of lupus disease activity by combining patient and physician assessments.